Nasdaq Delisting Notice: bioAffinity Falls Below $1 Bid, Ineligible for Standard Cure Period
BIAF is trading near its 52-week low of $0.56 (6.9% above the low) on light trading volume (0.3× avg).
Summary
bioAffinity Technologies received a Nasdaq delisting notice for failing the $1 minimum bid price rule and is ineligible for the standard cure period due to a prior reverse split. The company will appeal, but delisting risk is acute given its fragile financial position.
Key Events · Legal and Risk Events · BIAF
-
Nasdaq Delisting Notice Received
On July 30, 2026, Nasdaq notified bioAffinity that its stock closed below $1.00 for 30 consecutive business days, violating the minimum bid price requirement.
-
Ineligible for Standard 180-Day Cure
Due to a 1-for-30 reverse stock split on September 19, 2025, the company is not eligible for the usual 180-day compliance period under Nasdaq Rule 5810(c)(3)(A)(iv).
-
Appeal Planned for August 6
The company intends to appeal the Staff Determination on August 6, 2026, which will stay delisting pending a hearing before a Nasdaq Hearings Panel.
-
No Assurance of Extension or Compliance
The company cannot guarantee the Panel will grant an extension or that it will regain compliance with the bid price rule, putting its Nasdaq listing at immediate risk.
Analysis · BIAF · Industrial Applications And Services
A Nasdaq Staff Determination landed on July 30, 2026, after bioAffinity Technologies' stock closed below $1 for 30 consecutive business days. Because the company executed a 1-for-30 reverse split in September 2025, it is not eligible for the standard 180-day compliance period. An appeal is planned for August 6, which stays delisting pending a hearing, but there is no guarantee the Panel will grant an extension or that the company can regain compliance. With a market cap under $4 million and a cash runway that was already critical as of June 2026, a delisting would severely impair liquidity and access to capital, threatening the company's survival.
At the time of this filing, BIAF was trading at $0.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $0.56 to $13.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.